Delivery Order SPE2DB25D3306-SPE2DB25FUCJQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,942.92 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, a medication used to treat multiple sclerosis. This firm fixed price delivery order, awarded on August 26, 2025, represents a non-competitive, non-set-aside procurement with a completion date of August 27, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $16,283.25 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order, awarded on August 1, 2025, represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Betaseron 0.3 mg kits with a contract value of $36,290.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This delivery order operates...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,216.11, is for the delivery of Betaseron 0.3 mg kits, a medication used to treat multiple sclerosis. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits with a ceiling value of $82,716.10 under a firm fixed-price contract type. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for $61,750.04 to supply Betaseron 0.3 mg kits. This is a firm fixed-price delivery order with an ultimate completion date of July 8, 2025, and performance will be executed at the contractor's Conshohocken, Pennsylvania facility. The award was made without a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCJQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,153.78 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order as a child contract under its larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Betaseron, an interferon beta-1b medication used in the treatment of multiple sclerosis, is among the specialized pharmaceutical products procured through this strategic vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/28/25 |